Daniel Y Sze, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sze’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G75157 · Current
Licensed to practise in California · since 1992 · expires 2028-06-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$42,869
Medicare paid this office $42,869 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Occlusion of growths or obstructed vessels with review by radiologist | 16 | $8,906 | $469 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 16 | $3,189 | $139 |
| Review by radiologist of abdominal artery image | 14 | $1,630 | $81 |
| Review by radiologist of ct guidance for needle placement | 23 | $1,413 | $61 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 11 | $1,127 | $40 |
See all 8 services
| Occlusion of growths or obstructed vessels with review by radiologist | 16 | $8,906 | $469 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 16 | $3,189 | $139 |
| Review by radiologist of abdominal artery image | 14 | $1,630 | $81 |
| Review by radiologist of ct guidance for needle placement | 23 | $1,413 | $61 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 11 | $1,127 | $40 |
| Needle biopsy of liver through skin | 14 | $1,053 | $75 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 61 | $704 | $11 |
| Ultrasonic guidance for blood vessel access | 23 | $347 | $12 |
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 74 · Women 42% · Also on Medicaid 28% · Health risk score 2.33. Above the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 38% · Cancer 33% · Diabetes 29% · Chronic kidney disease 29% · Heart failure 23% · Atrial fibrillation 23% · Depression 21% · COPD 17% · Stroke 12%.
The office billed $1,352,714, Medicare allowed $54,073 and paid $42,869; for 434 services of 79 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 90 | 434 | 74 | 2.33 | $1,352,714 | $42,869 |
| 2023 | 94 | 404 | 71 | 2.98 | $981,128 | $40,165 |
| 2022 | 116 | 646 | 72 | 3.11 | $1,044,665 | $59,299 |
| 2021 | 103 | 521 | 73 | 2.86 | $864,570 | $51,865 |
| 2020 | 136 | 782 | 72 | 2.76 | $1,179,167 | $79,943 |
| 2019 | 161 | 951 | 71 | 3.29 | $1,455,960 | $91,863 |
| 2018 | 137 | 598 | 72 | 2.99 | $764,455 | $52,552 |
| 2017 | 148 | 817 | 69 | 2.50 | $1,265,394 | $82,454 |
| 2016 | 156 | 824 | 70 | 2.72 | $1,361,439 | $90,907 |
| 2015 | 158 | 804 | 72 | 2.87 | $1,116,731 | $86,202 |
| 2014 | 172 | 1,018 | 70 | 2.50 | $1,538,999 | $113,620 |
| 2013 | 189 | 1,047 | 69 | 2.90 | $1,280,913 | $122,904 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Occlusion of growths or obstructed vessels with review by radiologist | 17 | $8,384 | $493 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 17 | $3,247 | $148 |
| Review by radiologist of abdominal artery image | 14 | $1,963 | $85 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 13 | $929 | $42 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $387 | $35 |
| Ultrasonic guidance for blood vessel access | 24 | $362 | $12 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 51 | $275 | $5 |
2022: 9 services
| Occlusion of growths or obstructed vessels with review by radiologist | 22 | $11,730 | $489 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 26 | $5,340 | $148 |
| Review by radiologist of abdominal artery image | 26 | $3,348 | $86 |
| Review by radiologist of additional artery image | 23 | $2,817 | $42 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 26 | $2,472 | $43 |
| 3d radiographic procedure with computerized image postprocessing | 16 | $606 | $36 |
| Ultrasonic guidance for blood vessel access | 34 | $533 | $12 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 85 | $479 | $5 |
| Ultrasonic guidance for needle placement | 12 | $336 | $28 |
2021: 8 services
| Occlusion of growths or obstructed vessels with review by radiologist | 14 | $9,112 | $506 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 19 | $4,342 | $150 |
| Review by radiologist of abdominal artery image | 19 | $3,501 | $88 |
| Review by radiologist of additional artery image | 15 | $1,370 | $43 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 17 | $1,179 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 62 | $826 | $11 |
| Ultrasonic guidance for blood vessel access | 25 | $493 | $13 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $434 | $36 |
2020: 12 services
| Occlusion of growths or obstructed vessels with review by radiologist | 23 | $14,675 | $524 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 27 | $6,788 | $154 |
| Occlusion of artery with review by radiologist | 11 | $5,622 | $432 |
| Review by radiologist of abdominal artery image | 31 | $5,208 | $90 |
| Review by radiologist of additional artery image | 27 | $4,245 | $44 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 24 | $3,082 | $45 |
| Review by radiologist of ct guidance for needle placement | 28 | $1,862 | $66 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 11 | $1,465 | $113 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 94 | $1,255 | $11 |
| 3d radiographic procedure with computerized image postprocessing | 24 | $1,067 | $37 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 12 | $857 | $71 |
| Ultrasonic guidance for blood vessel access | 36 | $517 | $13 |
2019: 13 services
| Occlusion of growths or obstructed vessels with review by radiologist | 27 | $20,580 | $515 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 36 | $8,613 | $146 |
| Occlusion of artery with review by radiologist | 16 | $6,973 | $410 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 28 | $3,229 | $44 |
| Review by radiologist of abdominal artery image | 31 | $2,969 | $49 |
| Review by radiologist of ct guidance for needle placement | 35 | $2,358 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,686 | $11 |
| 3d radiographic procedure with computerized image postprocessing | 28 | $1,417 | $36 |
| Radioactive drug therapy through a tube inserted in an artery | 12 | $1,252 | $104 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 14 | $1,136 | $81 |
| Review by radiologist of additional artery image | 25 | $955 | $15 |
| Ultrasonic guidance for blood vessel access | 45 | $755 | $13 |
| Ultrasonic guidance for needle placement | 11 | $322 | $29 |
2018: 10 services
| Occlusion of growths or obstructed vessels with review by radiologist | 18 | $11,184 | $508 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 24 | $4,150 | $143 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 19 | $1,567 | $44 |
| Review by radiologist of ct guidance for needle placement | 30 | $1,545 | $52 |
| Review by radiologist of abdominal artery image | 21 | $1,326 | $49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 108 | $1,291 | $11 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 15 | $1,248 | $83 |
| Review by radiologist of additional artery image | 20 | $758 | $15 |
| 3d radiographic procedure with computerized image postprocessing | 17 | $751 | $36 |
| Ultrasonic guidance for blood vessel access | 22 | $359 | $13 |
2017: 14 services
| Occlusion of growths or obstructed vessels with review by radiologist | 37 | $21,516 | $512 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 40 | $7,652 | $147 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 30 | $3,467 | $44 |
| Review by radiologist of abdominal artery image | 37 | $3,311 | $49 |
| Long return visit (40+ min) | 19 | $2,219 | $96 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 13 | $2,043 | $108 |
| Review by radiologist of additional artery image | 35 | $1,599 | $16 |
| Review by radiologist of ct guidance for needle placement | 31 | $1,595 | $51 |
| 3d radiographic procedure with computerized image postprocessing | 34 | $1,481 | $36 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 13 | $1,048 | $81 |
| Insertion of tube into vein, first order branch | 14 | $930 | $66 |
| Return visit (30+ min) | 11 | $776 | $60 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $775 | $11 |
| Ultrasonic guidance for blood vessel access | 14 | $192 | $13 |
2016: 9 services
| Occlusion of growths or obstructed vessels with review by radiologist | 38 | $28,787 | $523 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 42 | $9,817 | $153 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 40 | $5,145 | $44 |
| Review by radiologist of abdominal artery image | 41 | $3,060 | $49 |
| Review by radiologist of additional artery image | 38 | $2,233 | $16 |
| Review by radiologist of ct guidance for needle placement | 33 | $1,707 | $52 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 16 | $1,519 | $95 |
| 3d radiographic procedure with computerized image postprocessing | 30 | $1,427 | $36 |
| Return visit (30+ min) | 12 | $1,091 | $57 |
2015: 12 services
| Occlusion of growths or obstructed vessels with review by radiologist | 31 | $20,991 | $512 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 36 | $7,622 | $149 |
| Occlusion of artery with review by radiologist | 13 | $5,976 | $427 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 29 | $4,053 | $44 |
| Review by radiologist of abdominal artery image | 36 | $2,440 | $50 |
| Review by radiologist of additional artery image | 34 | $1,909 | $16 |
| Return visit (30+ min) | 15 | $1,472 | $70 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 16 | $1,383 | $86 |
| 3d radiographic procedure with computerized image postprocessing | 29 | $1,353 | $36 |
| Review by radiologist of ct guidance for needle placement | 25 | $1,270 | $51 |
| Long return visit (40+ min) | 11 | $1,092 | $99 |
| Short return visit (20+ min) | 11 | $500 | $45 |
2014: 14 services
| Occlusion of growths or obstructed vessels with review by radiologist | 45 | $33,194 | $519 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 46 | $10,457 | $139 |
| Occlusion of artery with review by radiologist | 17 | $7,529 | $443 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 44 | $6,136 | $45 |
| Review by radiologist of abdominal artery image | 43 | $3,576 | $50 |
| Radioactive drug therapy through a tube inserted in an artery | 18 | $2,163 | $103 |
| 3d radiographic procedure with computerized image postprocessing | 42 | $2,094 | $35 |
| Review by radiologist of ct guidance for needle placement | 39 | $2,063 | $50 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 22 | $1,944 | $88 |
| Review by radiologist of additional artery image | 34 | $1,906 | $15 |
| New patient visit (45+ min) | 14 | $1,503 | $107 |
| Long return visit (40+ min) | 13 | $1,381 | $99 |
| Return visit (30+ min) | 13 | $825 | $63 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 12 | $629 | $31 |
2013: 20 services
| Insertion of catheter and device to stop blood flow or infusion to dissolve blood clot | 43 | $48,530 | $758 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 39 | $8,034 | $139 |
| Imaging of blood vessel | 40 | $4,009 | $72 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 30 | $3,795 | $44 |
| Insertion of stent into blood vessel | 11 | $3,785 | $315 |
| Review by radiologist of image for insertion of material to block blood flow | 43 | $3,486 | $56 |
| Review by radiologist of abdominal artery image | 38 | $3,073 | $48 |
| Long return visit (40+ min) | 13 | $1,625 | $96 |
| 3d radiographic procedure with computerized image postprocessing | 33 | $1,553 | $34 |
| Review by radiologist of additional artery image | 33 | $1,530 | $15 |
| New patient visit (45+ min) | 14 | $1,519 | $108 |
| Return visit (30+ min) | 17 | $1,428 | $59 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 11 | $1,009 | $92 |
| Drainage of fluid from abdominal cavity using imaging guidance | 13 | $799 | $61 |
| Review by radiologist of image for drainage of fluid | 14 | $754 | $50 |
| Review by radiologist of abdominal aorta image | 12 | $752 | $47 |
| Review by radiologist of ct guidance for needle placement | 14 | $687 | $49 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 16 | $518 | $30 |
| Radiological supervision and interpretation of placement of vascular stent procedure | 11 | $442 | $34 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $256 | $16 |
Medicaid work
$2,872 in 2024
Medicaid paid $2,872 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| FLUORO CENTRAL VENOUS ACCESS DEV PLACEMENT | 25 | $2,872 |
| 2024 | 25 | 1 | 13 | $2,872 |
| 2019 | 24 | 1 | 12 | $714 |
| 2018 | 53 | 2 | 13 | $1,346 |
See the largest Medicaid services in earlier years
2019
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 24 | $714 |
2018
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 40 | $1,094 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 13 | $252 |
Money from drug and device companies
$6,234 in 2025
| 2025 | 4 | 12 | $5,175 | $6,234 |
| 2024 | 6 | 12 | $5,355 | $6,357 |
| 2023 | 6 | 15 | $4,420 | $5,978 |
| 2022 | 4 | 13 | $8,740 | $9,696 |
| 2021 | 9 | 15 | $21,660 | $22,208 |
| 2020 | 6 | 17 | $29,915 | $42,224 |
| 2019 | 9 | 43 | $34,702 | $41,869 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| W. L. Gore & Associates | Product in Development | $5,656 | 7 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $438 | 3 payments
|
| ABK Biomedical USA | Eye90 Microspheres | $72 | 1 payment
|
| TriSalus Life Sciences | Trinav Infusion System | $67 | 1 payment
|
See all 12 published payments
| Sirtex Medical | Meals · 2025-12-24 | Sir-Spheres Microspheres | $152 |
| W. L. Gore & Associates | Meals · 2025-10-11 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $129 |
| ABK Biomedical USA | Meals · 2025-09-13 | Eye90 Microspheres | $72 |
| Sirtex Medical | Meals · 2025-06-03 | Sir-Spheres Microspheres | $138 |
| W. L. Gore & Associates | Meals · 2025-04-01 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $173 |
| W. L. Gore & Associates | Consulting · 2025-03-28 | Product in Development | $1,380 |
| W. L. Gore & Associates | Consulting · 2025-03-28 | Product in Development | $690 |
| W. L. Gore & Associates | Consulting · 2025-03-28 | Product in Development | $690 |
| TriSalus Life Sciences | Meals · 2025-03-12 | Trinav Infusion System | $67 |
| W. L. Gore & Associates | Meals · 2025-02-26 | Gore Viatorr Tips Endoprosthesis | $180 |
| Sirtex Medical | Meals · 2025-02-19 | Lava Les (Liquid Embolic System) | $148 |
| W. L. Gore & Associates | Consulting · 2025-01-31 | Product in Development | $2,415 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,357
| W. L. Gore & Associates | Product in Development | $5,355 | 3 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $442 | 3 payments
|
| Boston Scientific | Obsidio | $331 | 3 payments
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $136 | 1 payment
|
| Penumbra | Indigo System | $62 | 1 payment
|
| Ge Healthcare | Allia | $31 | 1 payment
|
2023: $5,978
| W. L. Gore & Associates | Product in Development | $4,420 | 3 payments
|
| Boston Scientific | Embold Fibered | $992 | 7 payments
|
| Cook Medical | Torcon Nb | $198 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $169 | 1 payment
|
| Bard Peripheral Vascular | Venovo | $104 | 1 payment
|
| Canon Medical Systems USA | Interventional Angiography System | $96 | 1 payment
|
2022: $9,696
| W. L. Gore & Associates | Product in Development | $7,540 | 3 payments
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $1,932 | 8 payments
|
| GE HealthCare | None | $148 | 1 payment
|
| Philips Electronics North America | (6554) Periph Vasc Undiv | $76 | 1 payment
|
2021: $22,208
| Sirtex Medical | Sir-Spheres Microspheres | $8,000 | 3 payments
|
| Boston Scientific | General Pain Management | $3,725 | 3 payments
|
| W. L. Gore & Associates | Gore Viatorr Tips Endoprosthesis | $3,640 | 2 payments
|
| Eisai | Lenvima | $2,520 | 1 payment
|
| Varian Medical Systems | None | $2,400 | 1 payment
|
| Terumo Medical | None | $1,500 | 2 payments
|
| Siemens Medical Solutions USA | Microthermx Microwave Ablation System | $154 | 1 payment
|
| Penumbra | Indigo System | $143 | 1 payment
|
| Cook Medical | Torcon Nb | $126 | 1 payment
|
2020: $42,224
| Sirtex Medical | Sir-Spheres Microspheres | $23,672 | 5 payments
|
| Varian Medical Systems | None | $7,409 | 3 payments
|
| W. L. Gore & Associates | Tag Thoracic Endoprosthesis | $7,365 | 4 payments
|
| Boston Scientific | General - Io Ablation | $2,929 | 3 payments
|
| Terumo Medical | None | $750 | 1 payment
|
| Cook Medical | Cook Medical Catheters | $98 | 1 payment
|
2019: $41,869
| Terumo Medical | Azur | $11,594 | 8 payments
|
| Surefire Medical | Precision Infusion System | $9,815 | 7 payments
|
| W. L. Gore & Associates | Product in Development | $8,782 | 7 payments
|
| Boston Scientific | General Therapies | $5,546 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $2,876 | 2 payments
|
| Biocompatibles | Therasphere - Bio | $1,700 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | None | $1,245 | 2 payments
|
| Varian Medical Systems | None | $207 | 2 payments
|
| Cook Medical | Cook Medical Catheters | $104 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merit Medical Systems Inc · Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer · 2020 | Their institution | $26,400 |
| Merit Medical Systems Inc · Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer · 2021 | Their institution | $17,600 |
| Merit Medical Systems Inc · Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (Hiquality) · 2019 | Their institution | $13,440 |
| Biocompatibles UK Ltd · Ready · 2019 | Their institution | $4,659 |
| Biocompatibles UK Ltd · Target Study · 2019 | Their institution | $2,734 |
| BOSTON SCIENTIFIC CORPORATION · Target Study · 2021 | Their institution | $2,454 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194882985
- Licence
- CA G75157California G75157: Current · expires 2028-06-30
- Trained
- Stanford University School of Medicine, 1991
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-02
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.